Surface preferred regimens at the point of care
Prioritize evidence-based medicine, clinical research, and site-specific preferences at the point of care with Flatiron Assist™, an EHR-integrated, oncology-specific clinical decision support platform.
Stay ahead of innovative treatment options
Flatiron Assist™ elevates clinical care by arming clinicians with innovative treatment insights at the point of care via an EHR-integrated, intuitive decision-support tool.
With instinctive workflows, up-to-date treatment guidelines, and actionable data, Flatiron Assist™ helps cancer centers and community oncologists improve the patient experience, streamline operations, and increase revenue.
Features
Surface the latest oncology clinical pathways at the point of care
Updated NCCN® content
Flatiron Assist™ surfaces NCCN® Guidelines for 24 diseases, covering 90% of orders. Guidelines are continually updated within Flatiron Assist™ to ensure access to the latest information, including new biomarkers to help identify the best precision cancer treatments.
Customizable content
In addition to NCCN® content, Flatiron Assist™ allows you to create custom treatment pathways and regimens to meet cancer center or payer preferences.
Streamlined prior authorization
Reduce the burden on administrative staff by capturing the data needed for prior authorization documentation in an easy-to-use structured format.
Enhanced data and reporting
Measure and analyze concordance, pathways compliance, clinician adoption, and care pattern variations at the clinician and location level.
Clinical trial opportunities
Flatiron Assist™ captures clinical trial data and surfaces it at the point of care based on patient clinical factors, helping clinicians easily identify research opportunities.
Flatiron Assist™ in action
By the numbers
>90%
Overall NCCN® concordance
80%
Clinician adoption after one year
75+
Updates of NCCN® guidelines in 2022
10%
Reduction in denial rate
2 day
Improvement in time to prior authorization
58%
Reduction in unique regimens ordered
“The nice thing about Flatiron Assist™ is that you can get right where you want to go—and get there quickly—without having to dig through an algorithm.”
Sylvia Richey, MD
Associate Medical Director, West Cancer Center
Partner spotlight
Dr. Christopher D'Avella sat down with the Journal of Clinical Pathways to discuss Penn Medicine’s Abramson Cancer Center's utilization of Flatiron Assist™ and how it led to a notable rise in provider engagement, enhanced efficiency through shortened session lengths, and increased adoption rates.
outcomes
How Flatiron Assist™ elevates clinical care
Quickly find and order the right treatments through a seamless EHR-embedded workflow.
Reduce the amount of time patients have to wait between diagnosis and treatment.
Speed up prior authorizations and reduce denials.
Stay up-to-date on evolving treatment guidelines with the latest NCCN® guidance.
Easily identify clinical trial opportunities for your patients based on clinical factors.
Use biomarker data to select the best targeted therapy for patients.
Explore more from Flatiron
Explore our clinical research product suite
Our clinical research product portfolio reduces burden through technology-supported trials and operational efficiencies, lowers costs and accelerates drug delivery to a diverse patient population, and supports teams from trial design up to FDA submission.
Products and services include:
Get in touch
Learn how Flatiron Assist™ supports clinical decisions in oncology.